Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)

Peer Review reports

Original Submission
15 Oct 2020	Submitted	Original manuscript
19 Jan 2021	Reviewed	Reviewer Report - Kirsty Loudon
26 Jan 2021	Author responded	Author comments - Sander RM Bus
Resubmission - Version 2
26 Jan 2021	Submitted	Manuscript version 2
Publishing
29 Jan 2021	Editorially accepted
19 Feb 2021	Article published	10.1186/s13063-021-05083-1

Back to article page